These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 12605375)

  • 1. Distribution of p53 alterations in a case of gliomatosis cerebri.
    Mawrin C; Lins H; Kirches E; Schildhaus HU; Scherlach C; Kanakis D; Dietzmann K
    Hum Pathol; 2003 Jan; 34(1):102-6. PubMed ID: 12605375
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of IDH1 mutations in gliomatosis cerebri, but only in tumors with additional solid component: evidence for molecular subtypes.
    Seiz M; Tuettenberg J; Meyer J; Essig M; Schmieder K; Mawrin C; von Deimling A; Hartmann C
    Acta Neuropathol; 2010 Aug; 120(2):261-7. PubMed ID: 20514489
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular genetic alterations in gliomatosis cerebri: what can we learn about the origin and course of the disease?
    Mawrin C
    Acta Neuropathol; 2005 Dec; 110(6):527-36. PubMed ID: 16222524
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of TP53 and PTEN in gliomatosis cerebri.
    Mawrin C; Kirches E; Schneider-Stock R; Scherlach C; Vorwerk C; Von Deimling A; Van Landeghem F; Meyermann R; Bornemann A; Müller A; Romeike B; Stoltenburg-Didinger G; Wickboldt J; Pilz P; Dietzmann K
    Acta Neuropathol; 2003 Jun; 105(6):529-36. PubMed ID: 12734658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of p53 and prognosis in children with malignant gliomas.
    Pollack IF; Finkelstein SD; Woods J; Burnham J; Holmes EJ; Hamilton RL; Yates AJ; Boyett JM; Finlay JL; Sposto R;
    N Engl J Med; 2002 Feb; 346(6):420-7. PubMed ID: 11832530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative assessment of the functional p53 status in glioma cells.
    Kim EL; Yoshizato K; Kluwe L; Meissner H; Warnecke G; Zapf S; Westphal M; Deppert W; Giese A
    Anticancer Res; 2005; 25(1A):213-24. PubMed ID: 15816541
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alterations of cell cycle regulators in gliomatosis cerebri.
    Mawrin C; Kirches E; Schneider-Stock R; Boltze C; Vorwerk CK; von Mawrin A; Kirches E; Schneider-Stock R; Boltze C; Vorwerk CK; von Mawrin A; Kirches E; Schneider-Stock R; Boltze C; Vorwerk CK; von Mawrin A; Kirches E; Schneider-Stock R; Boltze C; Vorwerk CK; von Deimling A; Stoltenburg-Didinge G; Bornemann A; Romeike B; Sellhaus B; Dietzmann K
    J Neurooncol; 2005 Apr; 72(2):115-22. PubMed ID: 15925990
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ethnicity delineates different genetic pathways in malignant glioma.
    Chen P; Aldape K; Wiencke JK; Kelsey KT; Miike R; Davis RL; Liu J; Kesler-Diaz A; Takahashi M; Wrensch M
    Cancer Res; 2001 May; 61(10):3949-54. PubMed ID: 11358811
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of molecular genetic alterations associated with tumor progression in a case of gliomatosis cerebri.
    Braeuninger S; Schneider-Stock R; Kirches E; Powers JM; Korones DN; Mawrin C
    J Neurooncol; 2007 Mar; 82(1):23-7. PubMed ID: 16955219
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Correlation of p53 immunoreactivity and sequencing in patients with glioma.
    Kyritsis AP; Xu R; Bondy ML; Levin VA; Bruner JM
    Mol Carcinog; 1996 Jan; 15(1):1-4. PubMed ID: 8561860
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular genetic analysis of p53 intratumoral heterogeneity in human astrocytic brain tumors.
    Ren ZP; Olofsson T; Qu M; Hesselager G; Soussi T; Kalimo H; Smits A; Nistér M
    J Neuropathol Exp Neurol; 2007 Oct; 66(10):944-54. PubMed ID: 17917588
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [An immunohistochemical study of the expression of the oncoprotein p53 in astrocytic gliomas of the cerebral hemispheres].
    Korshunov AG; Sycheva RV
    Arkh Patol; 1996; 58(6):37-42. PubMed ID: 9139592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High prevalence of p53 exon 4 mutations in soft tissue sarcoma.
    Das P; Kotilingam D; Korchin B; Liu J; Yu D; Lazar AJ; Pollock RE; Lev D
    Cancer; 2007 Jun; 109(11):2323-33. PubMed ID: 17429838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patient with multiple primary carcinomas including 4 separate oral cancers: study of p53 mutations and their implications for management.
    Fukuda M; Nakatsuka T; Kusama K; Sakashita H
    J Oral Maxillofac Surg; 2006 Nov; 64(11):1672-9. PubMed ID: 17052595
    [No Abstract]   [Full Text] [Related]  

  • 15. Genetic aberrations in gliomatosis cerebri support monoclonal tumorigenesis.
    Kros JM; Zheng P; Dinjens WN; Alers JC
    J Neuropathol Exp Neurol; 2002 Sep; 61(9):806-14. PubMed ID: 12230327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Gliomatosis cerebri: a biopsy and autopsy case report].
    San Millan B; Kaci R; Polivka M; Robert G; Héran F; Gueguen A; Mokhtari K; Gray F
    Ann Pathol; 2010 Feb; 30(1):25-9. PubMed ID: 20223351
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mutation analysis of DKK1 and in vivo evidence of predominant p53-independent DKK1 function in gliomas.
    Mueller W; Lass U; Wellmann S; Kunitz F; von Deimling A
    Acta Neuropathol; 2005 Mar; 109(3):314-20. PubMed ID: 15668788
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p53 Alterations and protein accumulation in benign breast tissue and breast cancer risk: a cohort study.
    Rohan TE; Li SQ; Hartwick R; Kandel RA
    Cancer Epidemiol Biomarkers Prev; 2006 Jul; 15(7):1316-23. PubMed ID: 16835330
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical implications of p53 tumor suppressor gene mutation and protein expression in esophageal adenocarcinomas: results of a ten-year prospective study.
    Casson AG; Evans SC; Gillis A; Porter GA; Veugelers P; Darnton SJ; Guernsey DL; Hainaut P
    J Thorac Cardiovasc Surg; 2003 May; 125(5):1121-31. PubMed ID: 12771886
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitochondrial DNA as a clonal tumor cell marker: gliomatosis cerebri.
    Kirches E; Mawrin C; Schneider-Stock R; Krause G; Scherlach C; Dietzmann K
    J Neurooncol; 2003 Jan; 61(1):1-5. PubMed ID: 12587789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.